Upstate Active Clinical Trials

Study Title:

CALGB 80803 - Randomized Phase II Trial of PET Scan-Directed Combined Modality Therapy in Esophageal Cancer

What is the purpose of the study?

This randomized phase II trial is studying PET scan imaging in assessing response in patients with esophageal cancer receiving combination chemotherapy.

Upstate Institutional Review Board (IRB) Number:

266808

Study Phase:

II

Patient Age Group:

Adults

Principal Investigator:

Jonathan Wright, MD

ClinicalTrials.Gov ID:

NCT01333033

For more information about this trial go to ClinicalTrials.Gov

Who can I contact for more information?

Name: Diane M Gould
Phone: 315-464-8235
Email: gouldd@upstate.edu

Return to Previous Page || Search Again